11 apr: 2nd UPDATE: Biomet 3Q Loss Widens On Charges; Sales Grow 5%
11 apr: States Could See More Tobacco Payments This Year
11-04-2012 23:21:00

Quest Diagnostics Names Rusckowski As President, CEO

Relateret indhold

DOW JONES NEWSWIRES

Quest Diagnostics Inc. (DGX) named Royal Philips Electronics NV (PHG, PHIA.AE) executive Stephen Rusckowski as its new president and chief executive, ending a six-month search for a successor to current CEO Surya Mohapatra.

Rusckowski's appointment is effective May 1 and he will also join the company's board. Rusckowski has served as CEO of Philips Healthcare, Royal Philips' largest unit, since 2006.

The management change could mark a new course for the company. Some decisions Quest made under Mohapatra--such as the acquisition of diagnostics company AmeriPath Inc. and an expansion into India--have been criticized by analysts.

Quest, the largest diagnostic-testing company in the U.S. by revenue, had been hurt by a decline in doctor-office visits as consumers have reined in their health-care spending since the recession. Last year, the company unveiled a restructuring initiative to reduce its costs by $500 million over the next three years to help it meet profit targets. In October, the company initiated a search for a replacement for Mohapatra, who held the titles of chairman, president and CEO.

Quest also appointed lead director Daniel C. Stanzione as its new non-executive chairman.

"Steve Rusckowski is uniquely qualified to be chief executive officer of Quest Diagnostics," Stanzione said. "He has built an enviable track record in health care by successfully driving growth, both organically and through disciplined, effective acquisitions. His emphasis on operational excellence has enabled him to deliver consistently impressive results."

In January, Quest reported its fourth-quarter earnings rose 14% as the company saw higher testing revenue and improved margins.

Shares closed at $59.57 Wednesday and were unchanged after hours. The stock is up 2.6% since the start of the year.

-By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; nathalie.tadena@dowjones.com

(END) Dow Jones Newswires

April 11, 2012 17:21 ET (21:21 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo færdig med at købe aktier for 15 milliarder

29-01-2015 13:22:39
Novo Nordisk afsluttede onsdag sit årelange aktietilbagekøb og har dermed brugt i alt 15 mia. kr. på at købe egne aktier tilbage fra markedet siden 30. januar 2..

Aktier/middag: Nordea nyder fortsat godt af regnskabssucces

29-01-2015 11:44:44
Støttet af positive kursmålsændringer lægger Nordea sig torsdag middag i spidsen af C20 Cap-indekset, der langsomt er krøbet mod nul-linjen efter en start på ha..

Vestas, Siemens og GE stod for 95 pct. af USA-markedet i 2014

29-01-2015 07:29:35
Der er tre totalt dominerende aktører på det amerikanske vindmøllemarked, og det er General Electric (GE), Siemens og Vestas.De tre vindmølleproducenter stod fo..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Coloplast kommer med tal i rødt marked
2
Coloplast skuffer analytikerne og justerer forventninger
3
Novo færdig med at købe aktier for 15 milliarder
4
Vestas, Siemens og GE stod for 95 pct. af USA-markedet i 2014
5
Nordea: Analytikerne hæver kursmål på stribe

Relaterede aktiekurser

Philips KON 24,74 -0,9% Fald i aktiekurs
Quest Diagnostics Inc 71,09 0,7% Stigning i aktiekurs
Koninklijke Philips N.V. 28,21 0,7% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.

Copyright Euroinvestor A/S 2015  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
29. januar 2015 23:23:52
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20150128.1 - EUROWEB4 - 2015-01-29 23:23:52 - 2015-01-29 23:23:52 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x